Deborah Birx - 10 Jul 2024 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Executive Officer, Director
Signature
/s/ Deborah Birx
Issuer symbol
ARMP
Transactions as of
10 Jul 2024
Net transactions value
-$73,258
Form type
4
Filing time
25 Apr 2025, 16:07:12 UTC
Previous filing
18 Mar 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Tax liability $61,439 -22,925 -8.8% $2.68 237,075 10 Jul 2024 Direct F1
transaction ARMP Common Stock Tax liability $11,819 -6,061 -2.6% $1.95 231,014 14 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.